Tissue engineering skin, construction method of tissue engineering skin and application of tissue engineering skin in evaluating moisturizing effect of hydro-optical needle product for injection
By constructing a full-thickness skin model of skin stem cells, the changes in moisturizing factors and proteins in the skin were detected, and the unified standards, model limitations and data reliability of the evaluation of moisturizing effect of water-light needle treatment were solved, and the formulation of personalized beauty solutions and cosmetic injections were realized. Quality evaluation.
Patent Information
- Application Number
- CN202411500863.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-25
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-10-25
AI Technical Summary
The existing water-light needle treatment moisturizing effect evaluation lacks unified standards, limitations of experimental models, poor data reliability and insufficient personalized evaluation, making it difficult to scientifically and accurately evaluate the moisturizing effect of beauty injections.
A full-thickness skin model constructed by skin stem cells was used to detect the changes in moisturizing factors and moisturizing-related proteins in the skin, and the moisturizing effect of water-light needles was objectively evaluated, and different injection methods were simulated by adjusting the model preparation process.
A more scientific and accurate evaluation of the moisturizing effect of cosmetic injections has been achieved, and the shortcomings of the prior art have been overcome, and it can be used for personalized solutions and evaluation of cosmetic injections quality.
Smart Images

Figure CN118995578A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medical effect evaluation, and in particular relates to a method for evaluating the moisturizing effect of a cosmetic injection. Background Art
[0002] The disclosure of this background information is intended to enhance understanding of the general background of the invention and should not necessarily be taken as an acknowledgment or any form of suggestion that this information constitutes the prior art already known to a person skilled in the art.
[0003] As people's living standards improve and their pursuit of beauty grows, non-surgical cosmetic therapies are becoming more and more popular. Among them, water light needles, as a fast, safe and effective means of skin improvement, have been widely used around the world. Water light needles are an injectable skin care therapy that uses a special instrument "water light gun" to inject hyaluronic acid, collagen and other beauty injections into the dermis just below the epidermis to improve the skin's gloss, moisturizing and overall appearance. Common nutrient solution ingredients include hyaluronic acid, vitamin C, vitamin B group, amino acids and other antioxidant ingredients.
[0004] Although hyaluronic acid injection therapy is widely used in the beauty industry, the current evaluation of its moisturizing effect mainly relies on clinical trials or simple in vitro experimental models. These methods have the following shortcomings: 1. Inconsistent evaluation standards: There is currently a lack of unified standards and methods for the evaluation of the moisturizing effect of hyaluronic acid injections on the market, which makes it difficult to compare the effects of different products. 2. Limitations of experimental models: Existing in vitro experimental models often use 2D cells and cannot fully reflect the real changes in the skin after hyaluronic acid injection treatment. 3. Data reliability: Due to differences in experimental conditions and limitations on sample size, existing evaluation methods often find it difficult to obtain sufficiently reliable data support. 4. Insufficient personalized evaluation: Existing evaluation methods often use general methods and fail to take into account the differences in skin types and needs of different individuals. Therefore, it is an urgent problem to develop a new evaluation method that can overcome the above-mentioned defects of the existing technology to achieve a more scientific and accurate evaluation of the moisturizing effect after hyaluronic acid injection treatment. Summary of the invention
[0005] In view of the current lack of effective methods for evaluating the moisturizing effects of cosmetic injections, the present invention provides a method for evaluating the moisturizing effects of cosmetic injections. A full-thickness skin model constructed using skin stem cells can objectively evaluate the moisturizing efficacy of hyaluronic acid injections through changes in moisturizing factors and moisturizing-related proteins in the skin. Different injection methods of hyaluronic acid injections can also be simulated by adjusting the model preparation process.
[0006] To achieve the above purpose, the present invention adopts the following technical solution.
[0007] A method for constructing tissue-engineered skin containing inclusions, comprising the following steps: S1, placing the inclusion solution between the fibroblast gels in a transwell chamber and culturing with medium I to obtain a tissue-engineered dermis layer containing the inclusions; S2. Epidermal stem cells are inoculated on the tissue-engineered dermis layer and cultured in medium II to obtain tissue-engineered skin containing inclusions.
[0008] Fibroblast gels were formed using fibroblasts and type I collagen, where the density of fibroblasts was (3-6)×10 5 / mL, and the concentration of type I collagen is (1.5-5) mg / mL.
[0009] The formula of medium I is: DMEM 10g / L-20g / L, fetal bovine serum 5%-15%, glutamine 2mol / L-5mol / L, penicillin / streptomycin 0.1%-1.5%, NaHCO 3 4g / L-8g / L, adjust pH to 7.0-7.2.
[0010] The number of epidermal stem cells seeded is (1.5-3)×10 5 indivual.
[0011] The formula of culture medium II is: DMEM 8g / L-15g / L, F12 2g / L-8g / L, fetal bovine serum 0.1%-1%, glutamine 2mol / L-5mol / L, EGF 0.2ng / mL-2ng / mL, hydrocortisone 80ng / mL-100ng / mL, insulin 1μg / L-5μg / L.
[0012] Specifically, S1 is to place part of the liquid fibroblast gel in the transwell chamber to solidify and form a concave surface, then place the content solution on the concave fibroblast gel, and then cover it with the liquid fibroblast gel to solidify.
[0013] A tissue engineered skin containing inclusions obtained by the above method.
[0014] The contents may be water, buffer, cosmetic injection or pharmaceutical ingredients.
[0015] A method for culturing the tissue-engineered skin containing the above-mentioned inclusions comprises the following steps: The tissue-engineered skin containing the inclusions was subjected to air-liquid culture using medium III; The formula of the culture medium III is: DMEM 8g / L-15g / L, F12 2g / L-8g / L, fetal bovine serum 0.1%-1%, glutamine 2mol / L-5mol / L, EGF 0.2ng / mL-2ng / mL, hydrocortisone 80ng / mL-100ng / mL, insulin 1μg / L-5μg / L, palmitic acid 0.020mM-0.028mM, arachidonic acid 0.006-0.008mM, linoleic acid 0.012mM-0.018mM, and vitamin C 0.25mM-0.30mM.
[0016] A method for evaluating the moisturizing effect of a cosmetic injection comprises the following steps: (1) Constructing and culturing tissue-engineered skin containing contents; (2) Detect the content of related substances in tissue-engineered skin after culture; (3) Statistical analysis was performed on the contents of related substances in tissue-engineered skins whose contents were water and those whose contents were cosmetic injections, with a significant increase being the standard for moisturizing effects.
[0017] Step (1) includes the following steps: (1a) placing the solution of the contents between the fibroblast gels in a transwell chamber and culturing with medium I to obtain a tissue-engineered dermis layer containing the contents; (1b) inoculating epidermal stem cells onto the tissue-engineered dermis layer and culturing them in medium II to obtain tissue-engineered skin containing contents; (1c) Tissue-engineered skin containing contents was cultured in air-liquid medium III to obtain a tissue-engineered skin model containing contents.
[0018] Fibroblast gels were formed using fibroblasts and type I collagen, where the density of fibroblasts was (3-6)×10 5 The concentration of type I collagen is (1.5-5) mg / mL. Preferably, the passage number of the fibroblasts is within 5 generations.
[0019] The formula of medium I is: DMEM 10g / L-20g / L, fetal bovine serum 5%-15%, glutamine 2mol / L-5mol / L, penicillin / streptomycin 0.1%-1.5%, NaHCO 3 4g / L-8g / L, adjust pH to 7.0-7.2.
[0020] The number of epidermal stem cells seeded is (1.5-3)×10 5 Preferably, the epidermal stem cells have been passaged for 5 generations or less.
[0021] The formula of culture medium II is: DMEM 8g / L-15g / L, F12 2g / L-8g / L, fetal bovine serum 0.1%-1%, glutamine 2mol / L-5mol / L, EGF 0.2ng / mL-2ng / mL, hydrocortisone 80ng / mL-100ng / mL, insulin 1μg / L-5μg / L.
[0022] The formula of culture medium III is: DMEM 8g / L-15g / L, F12 2g / L-8g / L, fetal bovine serum 0.1%-1%, glutamine 2mol / L-5mol / L, EGF 0.2ng / mL-2ng / mL, hydrocortisone 80ng / mL-100ng / mL, insulin 1μg / L-5μg / L, palmitic acid 0.020mM-0.028mM, arachidonic acid 0.006-0.008mM, linoleic acid 0.012mM-0.018mM, vitamin C 0.25mM-0.30mM.
[0023] Culture medium I is a proliferation culture medium for dermal fibroblasts in the dermis, culture medium II is a proliferation culture medium for dermal fibroblasts and epidermal stem cells in tissue-engineered skin, and culture medium III is a proliferation and differentiation culture medium for dermal fibroblasts and epidermal stem cells in a tissue-engineered skin model, which promotes the proliferation of dermal fibroblasts and the proliferation and differentiation of epidermal stem cells. Any other culture medium that can achieve the above functions can be used as a culture medium for constructing a tissue-engineered skin model. However, compared with other culture media, the culture medium formula provided by the present invention can make the dermis model reflect the differences in the content of related substances in different inclusions more quickly.
[0024] The main ingredients of cosmetic injections are hyaluronic acid and its derivatives and / or collagen. Conventional testing of hyaluronic acid, collagen or their related amino acid content, hyaluronic acid binding protein (HABP), hyaluronic acid synthase 2 (HAS2) and other test indicators will be interfered by the ingredients in the injection and cannot truly reflect the effect. Therefore, in step (2), the relevant substances include at least one of urocanic acid (UCA), pyrrolidone carboxylic acid (PCA), aquaporin-3 (AQP3), and CD44 protein.
[0025] Correspondingly, in step (3), the standard for moisturizing effect is that the content of at least one of urocanic acid (UCA), pyrrolidone carboxylic acid (PCA), aquaporin-3 (AQP3), and CD44 protein is significantly increased, and the standard for judging significant increase is that P is at least at the 0.05 level; variance analysis can be performed at levels such as P=0.05, P=0.01, P=0.001, etc.; preferably, the P value is 0.01. The P value is the probability of observing the current statistic or a more extreme statistic under the condition that the null hypothesis is true. In some embodiments, the standard for moisturizing effect is that the P values of urocanic acid (UCA) and aquaporin-3 (AQP3) are less than 0.05, and the P values of pyrrolidone carboxylic acid (PCA) and CD44 protein are less than 0.01.
[0026] The endpoints and any values of the ranges disclosed in this application are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be regarded as specifically disclosed in this application.
[0027] The present invention has the following advantages: The present invention uses stem cells to construct a full-thickness skin model containing a cosmetic injection, and reflects the moisturizing effect of the cosmetic injection by detecting the content of a specific target molecule. The preparation process of the method is simple, highly repeatable, and easy to construct a standardized evaluation standard, avoiding the problem that the evaluation results of a single type of cells deviate greatly from the actual effect and the results vary greatly between different laboratories. The method can be used to evaluate the effect of an injection on an individual, formulate a personalized cosmetic plan, and can also be used to evaluate the quality effect of a cosmetic injection. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 It is the liquid chromatogram of urocanic acid in the control sample a and the test sample b; Figure 2 is the liquid chromatogram of pyrrolidone carboxylic acid in the reference sample a and the test sample b; Figure 3 It is the immunofluorescence staining image of AQP3 and CD44 in the control sample a and the test sample b. DETAILED DESCRIPTION
[0029] The present invention will be further described below in conjunction with embodiments and drawings, but the present invention is not limited by the following embodiments.
[0030] Example 1 Construction and culture of tissue-engineered skin containing cosmetic injections The cosmetic injection used in this embodiment has hyaluronic acid as its main component, and also contains creatine, vitamin B2, and amino acids. The content of hyaluronic acid is 5 mg / mL, and the solvent is normal saline.
[0031] Prepare different culture media I, II and III according to the following formulas and filter and sterilize them for later use: Medium I: DMEM 10 g / L, fetal bovine serum 10%, glutamine 2 mol / L, penicillin / streptomycin 1%, NaHCO 3 4g / L, adjust pH to 7.2; Medium II: DMEM 10 g / L, F12 5 g / L, fetal bovine serum 0.5%, glutamine 2 mol / L, EGF 1 ng / mL, hydrocortisone 100 ng / mL, insulin 2.5 μg / L; Culture medium III: DMEM 10 g / L, F12 5 g / L, fetal bovine serum 0.5%, glutamine 2 mol / L, EGF 1 ng / mL, hydrocortisone 100 ng / mL, insulin 2.5 μg / L, palmitic acid 0.024 mM, arachidonic acid 0.007 mM, linoleic acid 0.012 mM, vitamin C 0.30 mM.
[0032] Tissue-engineered skin was constructed and cultured as follows: S1. Collect the third generation fibroblasts and prepare a cell suspension with a density of 2 million / mL using medium I; mix 2 mL of 3 mg / mL type I collagen and 0.5 mL of fibroblast suspension to form a liquid fibroblast gel, add it to a six-well transwell chamber, and then place a plastic ring on it. After the collagen is semi-solidified, remove the plastic ring to obtain a concave fibroblast gel; Take 200 μL of cosmetic injection and add it to the concave surface, then add 2 mL of liquid fibroblast gel; after the collagen is completely solidified, add culture medium I inside and outside the small chamber to make the air-liquid interface inside and outside the small chamber level; CO 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity), incubate and culture for 3 days, replace the culture medium every day, and obtain a tissue-engineered dermis layer containing a cosmetic injection; S2, collecting the third generation epidermal stem cells and preparing a cell suspension with a density of 4 million / mL using medium II; The culture medium inside and outside the transwell chamber of the tissue-engineered dermis layer containing the cosmetic injection is discarded; then 500 μL of epidermal stem cell suspension is inoculated on the tissue-engineered dermis layer containing the cosmetic injection, and placed at room temperature for 1 hour. After the epidermal stem cells are completely attached to the wall, culture medium II is added inside and outside the chamber to make the air-liquid interface inside and outside the chamber level; CO 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity), incubate and culture for 3 days, replace the culture medium every day, and obtain tissue-engineered skin containing cosmetic injections; S3, discard the culture medium II inside and outside the cell, replace the culture medium III outside the cell, do not add culture medium inside the cell, and perform air-liquid culture on the tissue-engineered skin containing the cosmetic injection. 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity) for 10 days, changing the liquid every day to obtain test material b.
[0033] A control sample a containing water was prepared according to the above method.
[0034] Example 2 Evaluation of the moisturizing effect of cosmetic injections 1. Detection of epidermal moisturizing factor The test sample and control sample obtained in Example 1 were processed as follows: After cutting the test material along the edge of the chamber with a blade, use tweezers to remove the epidermis and transfer it to a 1.5mL centrifuge tube, add 500μL proteinase K working solution (concentration 0.2mg / mL) to each tube, and place it in a constant temperature incubator at 50℃ for enzymatic hydrolysis for 1h. Use tweezers to clamp the stratum corneum, place it in a new 1.5mL centrifuge tube, add 250μL methanol to each tube, and shake it with an ultrasonic oscillator for 30min. After the end, centrifuge at 14000rpm at 4℃ for 10min, aspirate the supernatant, transfer it to a new centrifuge tube, blow dry it with a nitrogen blow dryer, add 250μL pure water, and shake it with ultrasonic oscillation for 30min. After the end of the ultrasound, centrifuge at 12000rpm at 4℃ for 10min, aspirate 194μL supernatant into the inner liner tube, add 5μL 1M ammonium formate mother solution and 2.5μL acetonitrile to shake and mix, and obtain the sample solution to be tested.
[0035] The sample solution to be tested was subjected to high performance liquid chromatography detection, and the content of moisturizing factor was calculated using the external standard method: (1) Chromatographic conditions for urocanic acid (UCA) are as follows: a) Chromatographic column: C18 column, 5 μm, 4.6 × 250 mm; b) Mobile phase: 990 mL of ammonium formate solution (20 mmol / L) added with 10 mL of acetonitrile; c) Column temperature: 30°C; d) Mobile phase flow rate: 0.4 mL / min; e) Injection volume: 40 μL; f) Detection wavelength: 270nm; g) trans-UCA peak time: 9.9 min; cis-UCA peak time: 17.9 min; (2) The chromatographic conditions of pyrrolidone carboxylic acid (PCA) are the same as those of UCA, except that the detection wavelength is 210 nm and the peak elution time is 7.2 min.
[0036] Table 1 UCA and PCA contents in different samples The chromatograms of UCA and PCA in the sample solution to be tested are as follows: Figure 1 and 2 The contents are shown in Table 1. From the above data, it can be seen that the contents of trans-UCA, cis-UCA and PCA in the test samples are 1.50 times, 1.54 times and 1.51 times of those in the control samples, respectively. Compared with the control, the contents of trans-UCA, cis-UCA and PCA are significantly different (P < 0.05). This shows that compared with the control, the beauty injection can increase the content of beauty factors urocanic acid and pyrrolidone carboxylic acid in the epidermis; the constructed tissue engineered skin can reflect the effect of the beauty injection.
[0037] 2. Detection of moisturizing proteins The test sample and control sample obtained in Example 1 were processed as follows: The specimens were cut along the edge of the chamber with a blade, fixed with 4% paraformaldehyde, and paraffin-embedded sections were made. The paraffin sections were dehydrated, antigen repaired, serum blocked, primary and secondary antibodies were added in sequence, cell nuclei were counterstained with DAPI, and tissue autofluorescence was quenched before sealing. Fluorescence detection was then performed: DAPI channel indicated cell nuclei in blue, and CY3 channel positive indicated AQP3 and CD44 in red.
[0038] Table 2 Relative integrated optical density of different treatments The results are as follows Figure 3 As shown in Table 2, the above data show that the expression levels of AQP3 and CD44 in the test sample are 1.266 times and 1.109 times that in the control sample, respectively. Compared with the control, the expression levels of AQP3 and CD44 are significantly different (P < 0.05). This shows that compared with the control, the beauty injection can increase the expression levels of AQP3 and CD44 in the skin.
[0039] In summary, the tissue engineered skin containing inclusions provided by the present invention can be used to evaluate the moisturizing effect of cosmetic injections, drugs, etc. injected into the dermis.
[0040] Example 3 Construction and culture of tissue-engineered skin containing drug components Mix 50 mg of prednisone acetate suspension, 3 mL of 2% lidocaine injection, 2 mL of vitamin B1 injection, and 0.5 mg of vitamin B12 injection as dermal injection.
[0041] Prepare different culture media I, II and III according to the following formulas and filter and sterilize them for later use: Medium I: DMEM 12 g / L, fetal bovine serum 10%, glutamine 2.5 mol / L, penicillin / streptomycin 1%, NaHCO 3 4g / L, adjust pH to 7.2; Medium II: DMEM 10 g / L, F12 5 g / L, fetal bovine serum 0.8%, glutamine 2 mol / L, EGF 1 ng / mL, hydrocortisone 100 ng / mL, insulin 2.5 μg / L; Culture medium III: DMEM 10 g / L, F12 5 g / L, fetal bovine serum 1%, glutamine 2 mol / L, EGF 1 ng / mL, hydrocortisone 100 ng / mL, insulin 2.5 μg / L, palmitic acid 0.02 mM, arachidonic acid 0.008 mM, linoleic acid 0.015 mM, vitamin C 0.30 mM.
[0042] Tissue-engineered skin was constructed and cultured as follows: S1. Collect the third generation fibroblasts and prepare a cell suspension with a density of 2 million / mL using medium I; mix 2 mL of 3 mg / mL type I collagen and 0.5 mL of fibroblast suspension to form a liquid fibroblast gel, add it to a six-well transwell chamber, and then place a plastic ring on it. After the collagen is semi-solidified, remove the plastic ring to obtain a concave fibroblast gel; Take 200 μL of dermis injection solution and add it to the concave surface, then add 2 mL of liquid fibroblast gel; after the collagen is completely solidified, add culture medium I inside and outside the chamber to make the air-liquid interface inside and outside the chamber level; CO 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity), incubate and culture for 3 days, replace the culture medium every day, and obtain a tissue-engineered dermis layer containing drug components; S2, collecting the third generation epidermal stem cells and preparing a cell suspension with a density of 4 million / mL using medium II; The culture medium inside and outside the transwell chamber of the tissue-engineered dermis layer containing the drug component is discarded; then 500 μL of the epidermal stem cell suspension is inoculated on the tissue-engineered dermis layer containing the drug component, and placed at room temperature for 1 hour. After the epidermal stem cells are completely attached to the wall, culture medium II is added inside and outside the chamber to make the air-liquid interface inside and outside the chamber level; CO 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity), incubate and culture for 3 days, replace the culture medium every day, and obtain tissue-engineered skin containing drug components; S3, discard the culture medium II inside and outside the cell, replace the culture medium III outside the cell, do not add culture medium inside the cell, and perform air-liquid culture on the tissue-engineered skin containing drug ingredients. 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 The cells were incubated in a 95% relative humidity (95%) environment for 10 days with the medium changed every day. The obtained tissue-engineered skin can be used for the efficacy and toxicological evaluation of drug ingredients.
[0043] Example 4 Construction and culture of tissue-engineered skin containing PRP Collect 20 mL of venous blood into a centrifuge tube containing sodium heparin, centrifuge at 200 g for 10 min at 4°C, aspirate the supernatant into another centrifuge tube containing sodium heparin, centrifuge again, retain about 1 / 4 of the liquid at the bottom and shake well to obtain platelet-rich plasma (PRP); mix PRP with cross-linked hyaluronic acid for injection (composed of cross-linked sodium hyaluronate, lidocaine hydrochloride, non-cross-linked sodium hyaluronate, sodium chloride, disodium hydrogen phosphate, potassium dihydrogen phosphate, potassium chloride and water for injection, the total concentration of cross-linked and non-cross-linked sodium hyaluronate is 18 mg / mL, and the content of lidocaine hydrochloride is 3 mg / mL) in equal proportions to obtain a dermal injection.
[0044] Prepare different culture media I, II and III according to the following formulas and filter and sterilize them for later use: Medium I: DMEM 15 g / L, fetal bovine serum 10%, glutamine 2 mol / L, penicillin / streptomycin 1%, NaHCO 3 5g / L, adjust pH to 7.2; Medium II: DMEM 12 g / L, F12 6 g / L, fetal bovine serum 0.3%, glutamine 5 mol / L, EGF 1 ng / mL, hydrocortisone 80 ng / mL, insulin 2 μg / L; Culture medium III: DMEM 10 g / L, F12 5 g / L, fetal bovine serum 1%, glutamine 2 mol / L, EGF 0.5 ng / mL, hydrocortisone 100 ng / mL, insulin 2.5 μg / L, palmitic acid 0.028 mM, arachidonic acid 0.008 mM, linoleic acid 0.018 mM, vitamin C 0.30 mM.
[0045] Tissue-engineered skin was constructed and cultured as follows: S1. Collect the third generation fibroblasts and prepare a cell suspension with a density of 2 million / mL using medium I; mix 2 mL of 3 mg / mL type I collagen and 0.5 mL of fibroblast suspension to form a liquid fibroblast gel, add it to a six-well transwell chamber, and then place a plastic ring on it. After the collagen is semi-solidified, remove the plastic ring to obtain a concave fibroblast gel; Take 200 μL of dermis injection solution and add it to the concave surface, then add 2 mL of liquid fibroblast gel; after the collagen is completely solidified, add culture medium I inside and outside the chamber to make the air-liquid interface inside and outside the chamber level; CO 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity), incubate and culture for 3 days, replace the culture medium every day, and obtain a tissue-engineered dermis layer containing drug components; S2, collecting the third generation epidermal stem cells and preparing a cell suspension with a density of 4 million / mL using medium II; The culture medium inside and outside the transwell chamber of the tissue-engineered dermis layer containing the drug component is discarded; then 500 μL of the epidermal stem cell suspension is inoculated on the tissue-engineered dermis layer containing the drug component, and placed at room temperature for 1 hour. After the epidermal stem cells are completely attached to the wall, culture medium II is added inside and outside the chamber to make the air-liquid interface inside and outside the chamber level; CO 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 , 95% relative humidity), incubate and culture for 3 days, replace the culture medium every day, and obtain tissue-engineered skin containing drug components; S3, discard the culture medium II inside and outside the cell, replace the culture medium III outside the cell, do not add culture medium inside the cell, and perform air-liquid culture on the tissue-engineered skin containing drug ingredients. 2 Incubator (37 ± 1°C, 5 ± 1% CO 2 The cells were incubated in a 95% relative humidity (95%) environment for 10 days with the medium changed every day. The obtained tissue-engineered skin could be used for the evaluation of the efficacy and sensitization of drug ingredients.
[0046] The above is only an embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included in the scope of the claims of the present application.
Claims
1. A method for constructing tissue-engineered skin containing inclusions, characterized in that: The following steps are involved: S1, placing the inclusion solution between the fibroblast gels in a transwell chamber and culturing with medium I to obtain a tissue-engineered dermis layer containing the inclusions; S2. Epidermal stem cells are inoculated on the tissue-engineered dermis layer and cultured in medium II to obtain tissue-engineered skin containing inclusions.
2. The method according to claim 1, characterized in that Fibroblast gels were formed using fibroblasts and type I collagen, where the density of fibroblasts was (3-6)×10 5 / mL, the concentration of type I collagen is (1.5-5) mg / mL; The number of epidermal stem cells seeded is (1.5-3)×10 5 indivual.
3. The method according to claim 1, characterized in that The formula of medium I is: DMEM 10g / L-20g / L, fetal bovine serum 5%-15%, glutamine 2mol / L-5mol / L, penicillin / streptomycin 0.1%-1.5%, NaHCO3 4g / L-8g / L, pH adjusted to 7.0-7.2; The formula of culture medium II is: DMEM 8g / L-15g / L, F12 2g / L-8g / L, fetal bovine serum 0.1%-1%, glutamine 2mol / L-5mol / L, EGF 0.2ng / mL-2ng / mL, hydrocortisone 80ng / mL-100ng / mL, insulin 1μg / L-5μg / L.
4. The method according to claim 1, characterized in that S1 is to place part of the liquid fibroblast gel in the transwell chamber to solidify and form a concave surface, then place the content solution on the concave fibroblast gel, and then cover it with liquid fibroblast gel to solidify.
5. A tissue-engineered skin containing inclusions obtained by the method according to any one of claims 1 to 4.
6. The tissue-engineered skin containing inclusions according to claim 5, characterized in that: The contents are water, buffer solution, cosmetic injection or pharmaceutical ingredients.
7. A method for culturing tissue-engineered skin containing inclusions as claimed in claim 5 or 6, characterized in that: The following steps are involved: The tissue-engineered skin containing the inclusions was subjected to air-liquid culture using medium III; The formula of the culture medium III is: DMEM 8g / L-15g / L, F12 2g / L-8g / L, fetal bovine serum 0.1%-1%, glutamine 2mol / L-5mol / L, EGF 0.2ng / mL-2ng / mL, hydrocortisone 80ng / mL-100ng / mL, insulin 1μg / L-5μg / L, palmitic acid 0.020mM-0.028mM, arachidonic acid 0.006-0.008mM, linoleic acid 0.012mM-0.018mM, and vitamin C 0.25mM-0.30mM.
8. A method for evaluating the moisturizing effect of a cosmetic injection, characterized in that: The following steps are involved: (1) constructing a tissue-engineered skin containing contents as described in claim 5 or 6 and culturing it according to the method of claim 7; (2) Detect the content of related substances in tissue-engineered skin after culture; (3) Statistical analysis was performed on the contents of related substances in tissue-engineered skins with water content and cosmetic injection content, with a significant increase being the standard for moisturizing effect; In step (2), the related substance includes at least one of urocanic acid, pyrrolidone carboxylic acid, aquaporin-3, and CD44 protein.
9. The method according to claim 8, characterized in that In step (3), the significance criterion is that P is at least less than 0.
05.
10. The method according to claim 8, characterized in that In step (3), the significant judgment criteria are: the P value of urocanic acid and aquaporin-3 is less than 0.05, and the P value of pyrrolidone carboxylic acid and CD44 protein is less than 0.01.
Citation Information
Patent Citations
Tissue engineering artificial skin and preparation method thereof
CN104984407A
Method for building three-dimensional skin model applied to anti-inflammatory and anti-allergy effect evaluation
CN107267441A
Pigmentation skin model and method for producing same, and method for evaluating factor for treating or preventing pigmentation of skin
CN113166694A
Vascularized double-layer engineering skin based on 3D printing and preparation method thereof
CN113604421A
Preparation method and application of recombinant human 3D skin model
CN115960818A
Cited By
Differential medium of three-dimensional human epidermal organoid, preparation method and application thereof
CN121320229A
